The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity

Total Page:16

File Type:pdf, Size:1020Kb

The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Diallo, Alos Burgess. 2021. The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity. Master's thesis, Harvard University Division of Continuing Education. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37367694 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity Alos Diallo A Thesis in the Field of Bioinformatics for the Degree of Master of Liberal Arts in Extension Studies Harvard University March 2021 1 2 Copyright 2021 [Alos Diallo] Abstract T-cells are an essential component to the immune system, but they do not act alone and are instead a component in the body’s immune system. PD-1 and its ligands PD-L1 and PD-L2 play an important role in the regulation of T-cells which are incredibly important to the treatment of cancer. Tumors have been able to hijack the PD-1 inhibitory pathway to evade our body’s immune response. PD-1 pathway blockade, therefore, can serve as an important approach for cancer immunotherapy. However, we do not fully understand the mechanism by which PD-1 regulates anti-tumor immunity. With the datasets derived from experiments by the Sharpe Lab, we hope to answer two important questions. First, what does PD-1 regulate in a cell intrinsic manner compared to bystander effects on other cells in the tumor micro-environment? Second, which gene expression changes predict response as opposed to resistance to tumor clearance when PD-1 is present or deleted? We hypothesize that a cell intrinsic loss of PD-1 is necessary for improved T-cell fitness and effector functions. This project aims to help answer these questions in three ways. First, the development of an RNA-sequencing pipeline allows the researchers in the lab to analyze the results of datasets that are generated. Second, conducting pathway analyses provides a broader picture of the gene expression landscape, including provide a more complete picture of the tumor micro-environment by indicating which pathways and cellular processes are enriched for the genes affected by the deletion of PD-1. Third, the development of a statistical model which makes predictions on which gene expression changes predict response as opposed to resistance. 3 The results of the statistical model indicate which genes are more closely related to PD-1 when it is deleted versus when it is present. This will help us better understand immune response as opposed to resistance to PD-1 cancer immunotherapy, and its effects on tumor growth. This model therefore provides a valuable tool to the community that would allow researchers to probe the gene expression landscape around PD-1. 4 Dedication This work is dedicated to my parents, Abou Diallo and Sue Burgess. My parents have been a driving force and a positive influence on me and my success. They met in Senegal where my mother worked as an American Peace Corps volunteer, and my father worked as an instructor. Both have had to continuously make sacrifices and work hard for the good of our family. This often times meant one of them had to work at night. As a child, I watched them sacrifice selflessly for my sister and me. My father, more specifically, was unable to finish his own education so that he could build a better life for us. I saw him give up his dream of finishing college in order to work and provide for our family. I have never once heard him complain or ask for anything in return. Selflessness is a quintessential quality in my father, it is a part of who he is as a man. He was present for me to provide encouragement and advice whenever I considered giving up. From him, I learned that duty, honor and respect are part of a code that one should live by. From my mother, I learned to be curious and inquisitive. She enjoys going through records at churches, libraries, and city offices so she can research our family genealogy. She is always trying to find difficult to obtain ingredients to recipes she would like to replicate because she thinks we would enjoy them. Her inquisitive nature even led to travel abroad during a time when women were not expected nor encouraged to do so. Traveling the US, to Europe, and finally to Africa. I have become a better scientist by taking after my mother’s curious nature and I have gleaned what it means to be a man by observing my v father. I am and will be forever grateful and appreciative for their love, advice, influence and support of me. ARMA virumque cano, Troiae qui primus ab oris Italiam, fato profugus, Laviniaque venit litora, multum ille et terris iactatus et alto vi superum saevae memorem Iunonis ob iram –Aneid - Vergil vi Acknowledgments I would like to thank my advisor, Professor Arlene Sharpe, whose support and guidance makes this project possible. The Sharpe Lab Post-Doctoral Fellow, Kristen Pauken, has provided not only scientific advice on immunology but also logistic assistance for which I am thankful for. Kelly Burke, who is also a Post-Doctoral Fellow in the Sharpe lab has provided thoughtful advice and edits during this process, helping me to get the paper to its finished state. I would like to acknowledge Vikram Juneja, as he generated the data that I used for the thesis, without which the project would not be possible. Sarah Hillman, who is the administrative assistant to the Chair Arlene Sharpe has helped me with setting up invaluable meetings and provided general logistics support, for which I am thankful. I would also like to thank Steven Denkin, my research advisor, who helped me through the entire thesis process. He provided encouragement and thoughtful feedback in both the development of my thesis as well as with my research proposal. I want to thank the Thesis Coordinator, Gail Dourian, for helping me with the administrative thesis process. I feel it is important to also thank the two people who taught me what I know about statistical modeling. Andrey Sivachenko and Victor Farutin. I will always be grateful for what you taught me and for your encouragement. I would especially like to thank my parents Sue Burgess and Abou Diallo for their encouragement and support. Through their love I have garnered the strength to succeed. Finally, I would like to thank my wife, Jiaoyuan Elisabeth Diallo for helping me with the vii edits to my thesis. She helped me with all of the proofreading for this work. In addition she encouraged me and supported me when I really needed it most. viii Table of Contents Dedication ............................................................................................................................v Acknowledgments............................................................................................................. vii List of Tables ..................................................................................................................... xi List of Figures ................................................................................................................... xii Chapter I. Introduction .........................................................................................................1 Cancer Immunotherapy ............................................................................................3 Machine learning in medicine ..................................................................................5 Goals ........................................................................................................................9 Research Problem ..................................................................................................11 Chapter II. Materials and Methods ....................................................................................13 RNA Sequencing analysis......................................................................................19 Pathway Analysis ...................................................................................................24 The Statistical Model .............................................................................................27 Chapter III. Results ............................................................................................................37 RNA Sequencing analysis......................................................................................41 Pathway Analysis ...................................................................................................55 The Statistical model..............................................................................................69 Chapter IV. Discussion ......................................................................................................73 Limitations .............................................................................................................80 Future work ............................................................................................................81 ix Chapter V. Conclusion .......................................................................................................83 Chapter VI. Appendix ........................................................................................................84
Recommended publications
  • Doctoral Thesis Genetics of Male Infertility
    DOCTORAL THESIS GENETICS OF MALE INFERTILITY: MOLECULAR STUDY OF NON-SYNDROMIC CRYPTORCHIDISM AND SPERMATOGENIC IMPAIRMENT Deborah Grazia Lo Giacco November 2013 Genetics of male infertility: molecular study of non-syndromic cryptorchidism and spermatogenic impairment Thesis presented by Deborah Grazia Lo Giacco To fulfil the PhD degree at Universitat Autònoma de Barcelona Thesis realized under the direction of Dr. Elisabet Ars Criach and Prof. Csilla Krausz at the laboratory of Molecular Biology of Fundació Puigvert, Barcelona Thesis ascribed to the Department of Cellular Biology, Physiology and Immunology, Medicine School of Universitat Autònoma de Barcelona PhD in Cellular Biology Dr. Elisabet Ars Criach Prof. Csilla Krausz Dr. Carme Nogués Sanmiquel Director of the thesis Director of the thesis Tutor of the thesis Deborah Grazia Lo Giacco Ph.D Candidate A mis padres Agradecimientos Esta tesis es un esfuerzo en el cual, directa o indirectamente, han participado varias personas, leyendo, opinando, corrigiendo, teniéndo paciencia, dando ánimo, acompañando en los momentos de crisis y en los momentos de felicidad. Antes de todo quisiera agradecer a mis directoras de tesis, la Dra Csilla Krausz y la Dra Elisabet Ars, por su dedicación costante y continua a este trabajo de investigación y por sus observaciones y siempre acertados consejos. Gracias por haber sido mentores y amigas, gracias por transmitirme vuestro entusiasmo y por todo lo que he aprendido de vosotras. Mi más profundo agradecimiento a la Sra Esperança Marti por haber creído en el valor de nuestro trabajo y haber hecho que fuera posible. Quisiera agradecer al Dr. Eduard Ruiz-Castañé por su apoyo y ayuda constante, y a todos los médicos del Servicio de Andrología: Dr.
    [Show full text]
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Mir‑128‑3P Serves As an Oncogenic Microrna in Osteosarcoma Cells by Downregulating ZC3H12D
    ONCOLOGY LETTERS 21: 152, 2021 miR‑128‑3p serves as an oncogenic microRNA in osteosarcoma cells by downregulating ZC3H12D MAOSHU ZHU1*, YULONG WU2*, ZHAOWEI WANG3, MINGHUA LIN4, BIN SU5, CHUNYANG LI6, FULONG LIANG7 and XINJIANG CHEN6 Departments of 1Central Laboratory, 2Urinary Surgery, 3Gynecology, 4Pathology, 5Pharmacy, 6Orthopedics and 7Neurology, The Fifth Hospital of Xiamen, Xiang'an, Xiamen, Fujian 361000, P.R. China Received August 30, 2019; Accepted November 24, 2020 DOI: 10.3892/ol.2020.12413 Abstract. Osteosarcoma is the second leading cause of miR‑128‑3p‑mediated molecular pathway and how it is associ‑ cancer‑associated mortality worldwide in children and ated with osteosarcoma development. adolescents. ZC3H12D has been shown to negatively regulate Toll‑like receptor signaling and serves as a possible tumor Introduction suppressor gene. MicroRNAs (miRNAs/miRs) are known to play an important role in the proliferation of human osteo‑ As the most commonly occurring primary malignant bone sarcoma cells. However, whether miRNAs can affect tumor tumor, osteosarcoma accounts for >10% of all solid tumors development by regulating the expression of ZC3H12D has worldwide (1‑3). Osteosarcoma is the second leading cause of not yet been investigated. The aim of the present study was cancer‑associated mortality worldwide and primarily affects to investigate the role of miR128‑3p in regulating ZC3H12D young individuals, including children and adolescents (4,5). expression, as well as its function in tumor cell proliferation, Owing to advancements in surgical technology and combined apoptosis, and metastasis. Reverse transcription‑quantitative therapeutic strategies, the 5‑year overall survival rate of osteo‑ PCR, western blotting and dual luciferase reporter assays were sarcoma has increased to 60‑70% (6).
    [Show full text]
  • The Complete Genome Sequence of Mycobacterium Avium Subspecies Paratuberculosis
    The complete genome sequence of Mycobacterium avium subspecies paratuberculosis Lingling Li*†‡, John P. Bannantine‡§, Qing Zhang*†‡, Alongkorn Amonsin*†‡, Barbara J. May*†, David Alt§, Nilanjana Banerji†¶, Sagarika Kanjilal†‡¶, and Vivek Kapur*†‡ʈ *Department of Microbiology, †Biomedical Genomics Center, and ¶Department of Medicine, University of Minnesota, St. Paul, MN 55108; and §National Animal Disease Center, U.S. Department of Agriculture–Agriculture Research Service, Ames, IA 50010 Communicated by Harley W. Moon, Iowa State University, Ames, IA, July 13, 2005 (received for review March 18, 2005) We describe here the complete genome sequence of a common Map and Mav (11–13). Therefore, it is widely recognized that the clone of Mycobacterium avium subspecies paratuberculosis (Map) development of rapid, sensitive, and specific assays to identify strain K-10, the causative agent of Johne’s disease in cattle and infected animals is essential to the formulation of rational other ruminants. The K-10 genome is a single circular chromosome strategies to control the spread of Map. of 4,829,781 base pairs and encodes 4,350 predicted ORFs, 45 As a first step toward elucidating the molecular basis of Map’s tRNAs, and one rRNA operon. In silico analysis identified >3,000 physiology and virulence, and providing a foundation for the genes with homologs to the human pathogen, M. tuberculosis development of the next generation of Map diagnostic tests and (Mtb), and 161 unique genomic regions that encode 39 previously vaccines, we report the complete genome sequence of a common unknown Map genes. Analysis of nucleotide substitution rates clone of Map, strain K-10. with Mtb homologs suggest overall strong selection for a vast majority of these shared mycobacterial genes, with only 68 ORFs Materials and Methods with a synonymous to nonsynonymous substitution ratio of >2.
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • Molecular Genetics of Microcephaly Primary Hereditary: an Overview
    brain sciences Review Molecular Genetics of Microcephaly Primary Hereditary: An Overview Nikistratos Siskos † , Electra Stylianopoulou †, Georgios Skavdis and Maria E. Grigoriou * Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] (N.S.); [email protected] (E.S.); [email protected] (G.S.) * Correspondence: [email protected] † Equal contribution. Abstract: MicroCephaly Primary Hereditary (MCPH) is a rare congenital neurodevelopmental disorder characterized by a significant reduction of the occipitofrontal head circumference and mild to moderate mental disability. Patients have small brains, though with overall normal architecture; therefore, studying MCPH can reveal not only the pathological mechanisms leading to this condition, but also the mechanisms operating during normal development. MCPH is genetically heterogeneous, with 27 genes listed so far in the Online Mendelian Inheritance in Man (OMIM) database. In this review, we discuss the role of MCPH proteins and delineate the molecular mechanisms and common pathways in which they participate. Keywords: microcephaly; MCPH; MCPH1–MCPH27; molecular genetics; cell cycle 1. Introduction Citation: Siskos, N.; Stylianopoulou, Microcephaly, from the Greek word µικρoκεϕαλi´α (mikrokephalia), meaning small E.; Skavdis, G.; Grigoriou, M.E. head, is a term used to describe a cranium with reduction of the occipitofrontal head circum- Molecular Genetics of Microcephaly ference equal, or more that teo standard deviations
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • The Genetics of Bipolar Disorder
    Molecular Psychiatry (2008) 13, 742–771 & 2008 Nature Publishing Group All rights reserved 1359-4184/08 $30.00 www.nature.com/mp FEATURE REVIEW The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions A Serretti and L Mandelli Institute of Psychiatry, University of Bologna, Bologna, Italy Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome ‘hot regions’ for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF.
    [Show full text]
  • The Yin and Yang of Autosomal Recessive Primary Microcephaly Genes: Insights from Neurogenesis and Carcinogenesis
    International Journal of Molecular Sciences Review The Yin and Yang of Autosomal Recessive Primary Microcephaly Genes: Insights from Neurogenesis and Carcinogenesis Xiaokun Zhou 1, Yiqiang Zhi 1, Jurui Yu 1 and Dan Xu 1,2,* 1 College of Biological Science and Engineering, Institute of Life Sciences, Fuzhou University, Fuzhou 350108, China; [email protected] (X.Z.); [email protected] (Y.Z.); [email protected] (J.Y.) 2 Fujian Key Laboratory of Molecular Neurology, Institute of Neuroscience, Fujian Medical University, Fuzhou 350005, China * Correspondence: [email protected]; Tel.: +86-17085937559 Received: 17 December 2019; Accepted: 26 February 2020; Published: 1 March 2020 Abstract: The stem cells of neurogenesis and carcinogenesis share many properties, including proliferative rate, an extensive replicative potential, the potential to generate different cell types of a given tissue, and an ability to independently migrate to a damaged area. This is also evidenced by the common molecular principles regulating key processes associated with cell division and apoptosis. Autosomal recessive primary microcephaly (MCPH) is a neurogenic mitotic disorder that is characterized by decreased brain size and mental retardation. Until now, a total of 25 genes have been identified that are known to be associated with MCPH. The inactivation (yin) of most MCPH genes leads to neurogenesis defects, while the upregulation (yang) of some MCPH genes is associated with different kinds of carcinogenesis. Here, we try to summarize the roles of MCPH genes in these two diseases and explore the underlying mechanisms, which will help us to explore new, attractive approaches to targeting tumor cells that are resistant to the current therapies.
    [Show full text]
  • Allwithnames.Pdf
    Erythrocytes take up oxygen and release carbon dioxide AL1A1 ADH6ADHXADH7 ADH1G ADH1B ADH4 AL1B1 Cyclin E associated events during G1/S transition FRS-mediated FGFR4 signaling ADH1A CP2E1CP2B6 CP2A6 CP2CJCP2C8 CP2AD CP2C9 CP2D6 Pyrimidine salvageKHK TRP channels AL1A3 CP2J2Fanconi Anemia Pathway AL1A2 I23O1KMO Synthesis of bile acids and bile HYESsalts via 27-hydroxycholesterol AADATKYNUT23O Cobalamin (Cbl, vitamin B12) transport and metabolism CP3A5 ARMS-mediated activation Syndecan interactionsCP3A4 CP1A2 Tryptophan catabolism PANK3PANK2 Abacavir metabolism PANK1 Advanced glycosylation endproduct receptor signaling KCNK3 KCNK9 Loss of ALDH2proteins required for interphase microtubule organization from the centrosome XAV939 inhibits tankyrase, stabilizing AXIN Phase 2 - plateau phase KCNK2 Orc1 removal from chromatin Mineralocorticoid biosynthesis S22A6 S22ABS22AC CP26A Truncations of AMER1 destabilize the destruction complex Cytosolic sensorsPurine ribonucleoside of pathogen-associated monophosphate DNA biosynthesis ST1E1 UMPSPYRD CholineCGAT1 catabolism TPST2ST1A1 Separation ofTPH1 Sister Chromatids Methionine INMTsalvage pathway Phase 4 - restingHPPD membrane potential Classical antibody-mediatedKCNJ4 complement activation Phase I - Functionalization of compounds KCNJ2 Cargo recognition for clathrin-mediatedBODG endocytosis ENTP3ENTP1 CP1B1 ADAL ENTP2 CD38 Costimulation by the CD28 family N-glycan trimming in the ER and Calnexin/Calreticulin cycle METK2TPMT BHMT1 PGH1 Metalloprotease DUBs Retrograde neurotrophin signalling DHSO Caspase-mediated
    [Show full text]